We thank Drs Gerhard, Still, and DiStefano for their interest in our paper.1 These authors mainly draw attention to the prevalence of nonalcoholic steatohepatitis (NASH) in our prospective cohort of bariatric surgery patients (7.7% of NASH in 1540 obese patients), which was lower than in their own experience.